Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 1, 1996, Pages 298-305

  Mcmahon, James B ^a   Buckheit Jr , Robert W ^a,b   Gulakowski, Robert J ^a   Currens, Michael J ^a   Vistica, David T ^a   Shoemaker, Robert H ^a   Stinson, Sherman F ^a   Russell, Julie D ^a,b   Bader, John P ^a,c   Narayanan, Ven L ^a,c   Schultz, Robert J ^a,c   Brouwer, Walter G ^a,d   Felauer, Ethel E ^a,d   Boyd, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Uniroyal Chemical Ltd   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 [[(5,6 DIHYDRO 2 METHYL 1,4 OXATHIIN 3 YL)CARBONYL]AMINO]BENZOIC ACID ISOPROPYL ESTER; NSC 615985; NSC 629243; OXATHIIN DERIVATIVE; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; UC 38; UC 84; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CROSS RESISTANCE; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG POTENTIATION; DRUG STABILITY; HAMSTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BENZOATES; BIOLOGICAL AVAILABILITY; CARBOXIN; CRICETINAE; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; DRUG STABILITY; DRUG SYNERGISM; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MICE; MICROBIAL SENSITIVITY TESTS; RATS; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; THIOCARBAMATES; ZIDOVUDINE;

EID: 15844371369     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ANONYMOUS: NCI Decision Network Committee Meeting, Transcript, January, 1992.
2. BADER, J. P., MCMAHON, J. B., SCHULTZ, R. J., NARAYANAN, V. L., PIERCE, J. B., HARRISON, W A., WEISLOW, O. S., MIDELFORT, C. F., STINSON, S. F. AND BOYD, M. R.: Oxathiin carboxanilide, a potent inhibitor of human immunodeficiency virus reproduction. Proc. Natl. Acad. Sci. U.S.A. 88: 6740-6744, 1991.
3. BALZARINI, J., KARLSON, A., PEREZ-PEREZ, M -J. CAMARASA, M.-J., TARPLEY, W. G. AND DE CLERCQ, E.: Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single drug therapy J. Virol. 67: 5353-5359, 1993a.
4. BALZARINI, J., KARLSSON, A., PEREZ-PEREZ, M.-J., VRANG, L., WALBERS, J., ZHANG, H., OBERG, B., VANDAMME, A -M., CAMARASA M.-J. AND DE CLERCQ, E.: HIV-1 specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptase. Virology 192: 246-253, 1993b.
5. BALZARINI, J., PEREZ-PEREZ, M.-J., VELAZQUEZ, S., SAN-FELIX, A., CAMARASA, M.-J., DECLERCQ, E. AND KARLSSON, A : Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives). Proc. Natl. Acad. Sci. U.S.A. 92: 5470-5474, 1995.
6. BOYD, M R.: Strategies for the identification of new agents for the treatment of AIDS: A national program to facilitate the discovery and preclinical development of new drug candidates for clinical evaluation. In AIDS Etiology, Diagnosis, Treatment and Prevention, ed. by V. T. DeVita, Jr., S. Hellman and S. A. Rosenberg, pp. 305-317, Lippincott, Philadelphia, 1988.
7. BOYER, P. L., CURRENS, M. J., MCMAHON, J. B., BOYD, M. R. AND HUGHES, S. H.: Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 67: 2412-2420, 1993.
8. BUCKHEIT, R. W., JR , FLIAKAS-BOLTZ, V., DECKES, W. D., ROBERSON, J. L., PYLE, C. A., WHITE, E. L., BOWDON, B. J., MCMAHON, J. B., BOYD, M. R., BADER, J. P., NICKELL, O. G., BARTH, H. AND ANTONUCCI, T. K.: Biological and biochemical anti-HIV activity of the benzothiadiazine class of nonnucleoside reverse transcriptase inhibitors. Antiviral Res. 25: 43-56, 1994a.
9. BUCKHEIT, R. W., JR., FLIAKAS-BOLTZ, V., DECKER, W. D., ROBERSON, J. L., STUP, T. L., PYLE, C. A., WHITE, E. L., MCMAHON, J. B., CURRENS, M. J., BOYD, M. R. AND BADER, J. P.: Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic: subgroups. Antiviral Res. 26: 117-132, 1995.
10. BUCKHEIT, R. W., JR., HOLLINGSHEAD, M. G., GERMANY-DECKER, J., WHITE, E. L., MCMAHON, J. B., ALLEN, L B., ROSS, L. J., DECKER, W. D., WESTBROOK, L., SHANNON, W. M., WEISLOW, O., BADER, J. P. AND BOYD, M. R.: Thiazolobenzimidazole: Biological and biochemical antiretroviral activity of a nonnucleoside reverse transcriptase inhibitor. Antivir. Res. 21: 247-265, 1993.
11. BUCKHEIT, R. W., JR. AND SWANSTROM, R. I.: HIV-heterogeneity: Characterization of HIV-1 isolates displaying an apparent absence of virion-associated reverse transcriptase activity. AIDS Res. Human Retrovir. 7: 295-302, 1991.
12. BUCKHEIT, R. W., JR., WHITE, E. L., GERMANY-DECKER, J., ALLEN, L. B., ROSS, L. J., SHANNON, W. J., JANSSEN, P. A. J. AND CHIRIGOS, M. A.: Cell based and biochemical analysis of the anti-HIV activity of combinations of 3′-azido-3′-deoxythymidine and analogs of TIBO. Antiviral Chem. Chemother. 5: 35-42, 1994b.
13. COFFIN, J. M.: HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy Science (Wash. DC) 267: 483-489, 1995.
14. EMINI, E. A., SCHLELP, W. A., BYRNES, V. W., CONDRA, J. H., SARDANAL, V. Y., KAPPES, J. C , SAAG, M. AND SHAW, G.: In vitro and in vivo derivation of HIV-1 variants resistant to inhibition by the nonnucleoside reverse transcriptase inhibitor L-697,661. In Abstracts of the HIV Drug-Resistance Workshop, July 16-18, p. 14, Noordwijk, The Netherlands, 1992.
15. FULLER, R. W., BOKESCH, H. R., GUSTAFSON, K. R., MCKEE, T. C , CARDELLINA, J. H. II, MCMAHON, J. B., CRAGG, G. M , SOEJARTO, D. D. AND BOYD, M. R.: HIV-inhibitory coumarins from latex of the tropical rainforest tree Calophyllum teysmannii var. inophylloide. Bioorg. Med. Chem. Lett 4: 1961-1964, 1994.
16. GOLDMAN, M. E., NUNBERT, J H., O'BRIEN, J. A., QUINTERO, J. C., SCHLEIF, W. A., FREUND, K. F., GAUL, S. L., SAARI, W. S., WAI, J. S., HOFFMAN, J. M., ANDERSON, P. S., HUPE, O. J., EMINI, E. A. AND STERN, A. M.: Pyridinone derivatives: Specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity. Proc. Natl. Acad. Sci. U.S.A. 88: 6863-6867, 1991.
17. GULAKOWSKI, R. J., MCMAHON, J. B., STALEY, P. G., MORAN, R. A. AND BOYD, M. R.: A semiautomated multiparameter approach for anti-HIV drug screening. J. Virol. Methods 33: 87-100, 1991.
18. HIZI, A., TAL, R., SHAHARABANY, M , CURRENS, M. J., BOYD, M R., HUGHES, S. H. AND MCMAHON, J. B.: Specific inhibition of the revere transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors. Antimicrob. Agents Chemother. 37: 1037-1042, 1993.
19. HO, D. D., NEUMANN, A. U., PERELSON, A. S., CHEN, W., LEONARD, J M. AND MARKOWITZ, M.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (Lond.) 373: 123-126, 1995.
20. KASHMAN, Y., GUSTAFSON, K. R., FULLER, R. W., CARDELLINA, J. H. II, MCMAHON, J. B., CURRENS, M. J , BUCKHEIT, R. W., JR., HUGHES, S. H., CRAGG, G. M. AND BOYD, M. R.: The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree Calophyllum lanigerum. J. Med. Chem. 35: 2735-2743, 1992.
21. KLUNDER, J. M., HARGRAVE, K. D., WEST, M., CULLEN, E., PAL, K., BEHNKE, M. L., KAPADIA, S R., MCNEAL, D. W., WU, J. C., CHOW, G. C. AND ADAMS, J.: Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinones. J. Med Chem. 35: 1887-1897, 1992.
22. MAASS, G., IMMENDOERFER, U., KOENIG, B., LESER, U., MUELLER, B., GOODY, R. AND PFAFF, E.: Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 37: 2612-2617, 1993.
23. MCMAHON, J. B., GULAKOWSKI, R. J., WEISLOW, O. S., SCHULTZ, R. J., NARAYANAN, V. L., CLANTON, D. J , PEDEMONTE, R., WASSMUNDT, F. W., BUCKHEIT, R. W., JR., DECKER, W. D , WHITE, E. L., BADER, J. P. AND BOYD, M. R.: Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicro. Agents Chemother. 37: 754-760, 1993.
24. MELLORS, J. W., DUTSCHMAN, G. E., IM, G.-J., TRAMONTANO, E., WINKLER, S. R. AND CHENG, Y.-C.: In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase. Mol. Pharmacol. 41: 446-451, 1992.
25. MERLUZZI, V. J., HARGRAVE, K. D., LABADIA, M., GROZINGER, K., SKOOG, M , WU, J. C., SHIH, C -K., ECKNER, K., HATTOX, S., ADAMS, J., ROSENTHAL, A. S., FAANES, R., ESKNER, R. J., KOUP, R. A. AND SULLIVAN, J. L.: Inhibition of HIV-1 replication by a non-nucleoside reverse transcriptase inhibitor. Science (Wash. DC) 250: 1411-1413, 1990.
26. NARA, P L. AND FISCHINGER, P. J.: Quantitative infectivity assay for HIV-1 and HIV-2. Nature (Lond.) 332: 469-470, 1988.
27. NUNBERG, J. H., SCHLEIF, W. A., BOOTS, E. J., O'BRIEN, J. A., QUINTERO, J. C., HOFFMAN, J. M., EMINI, E. A. AND GOLDMAN, M. E.: Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J. Virol. 65: 4887-4892, 1991.
28. PAUWELS, R., ANDRIES, K., DESMYTER, J., SCHOLS, D., KUKLA, M. J., BRESLIN, H. J., RAEYMAECKERS, A., VAN GELDER, J., WOESTENBORGHS, R., HEYKANTS, J., SCHELLEKENS, K., JANSSEN, M. A. C , DE CLERCQ, E. AND JANSSEN, P. A. J.: Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature (Lond.) 343: 470-474, 1990.
29. PRICHARD, M N. AND SHIPMAN, C., JR.: A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 14: 181-206, 1990.
30. RICHMAN, D., ROSENTHAL, A. S., SKOOG, M , ECKNER, R. J., CHOU, T.-C., SABO, J. P. AND MERLUZZI, V. J.: BI-RG-57 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob. Agents Chemother. 85: 305-308, 1991a.
31. RICHMAN, D., SHIH, C.-K., LOWY, I., ROSE, J., PRODANOVICH, P., GOFF, S. AND GRIFFIN, J.: Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc. Natl. Acad. Sci U.S.A. 88: 11241-11245, 1991b.
32. ROMERO, D. L., BUSSO, M., TAN, C.-K., REUSSER, P., PALMER, J. R., POPPE, S. M., ARISTOFF, P. A., DOWNERY, K. M., SO, A. G., RESNICK, L. AND TARPLEY, W. G.: Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. U.S.A. 88: 8806-8810, 1991.
33. RUBINEK, T., MCMAHON, J. B. AND HIZI, A : Inhibition of reverse transcriptase of human immunodeficiency virus type 1 and chimeric enzymes of human immunodeficiency viruses types 1 and 2 by two novel non-nueleoside inhibitors. FEBS Lett. 22: 299-303, 1994.
34. SAAG, M. S., EMINI, E A , LASKLN, O. L., DOUGLAS, J., LAPIDIS, W. I , SCHLEIF, W. A., WHITLEY, R. J., HILDEBRAND, C., BYRNES, V. W., KAPPES, J. C., ANDERSON, K. W., MASSARI, F. E. AND SHAW, G M.: A short-term clinical evaluation of 1-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. N. Engl J. Med. 329: 1065-1072, 1993.
35. STINSON, S. F., SCHULTZ, R. J. AND MALSPEIS, L.: Pharmacokinetics of UC 38-related congeners demonstrating in vitro activity against native and mutant strains of HIV. Proc. Natl. Acad. Sci. U.S.A. 36: 2173, 1995.
36. WEI, X., GHOSH, S. K., TAYLOR, M. E., JOHNSON, V. A., EMINI, E A., DEUTSCH, P., LIFSON, J. D., BONHOEFFER, S., NOWAK, M. A., HAHN, B. H., SAAG, M. S. AND SHAW, G. M: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (Lond.) 373: 117-122, 1995.